Skip to main content
Daniel Coyne, MD, Nephrology, Saint Louis, MO

DanielWCoyneMD

Nephrology Saint Louis, MO

Professor, Internal Medicine, Washington University School of Medicine

Dr. Coyne is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Coyne's full profile

Already have an account?

  • Office

    4921 Parkview Pl
    # Dv
    Saint Louis, MO 63110
    Phone+1 314-362-7603
    Fax+1 314-747-5213

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Nephrology, 1987 - 1989
  • Emory University School of Medicine
    Emory University School of MedicineResidency, Internal Medicine, 1983 - 1986
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 1983

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 1989 - 2025
  • OH State Medical License
    OH State Medical License 1990 - 1994
  • GA State Medical License
    GA State Medical License 1984 - 1989
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Nephrology
  • National Board of Physicians and Surgeons Internal Medicine
  • National Board of Physicians and Surgeons Nephrology

Clinical Trials

Publications & Presentations

PubMed

Other

Press Mentions

  • Akebia and GSK Will Grapple with Heightened Scrutiny of HIF PHIs After Roxadustat Concerns
    Akebia and GSK Will Grapple with Heightened Scrutiny of HIF PHIs After Roxadustat ConcernsAugust 24th, 2021
  • 1A? No Way. KDOQI Has Lost Its Way
    1A? No Way. KDOQI Has Lost Its WayMay 14th, 2021
  • Pooled Results of Roxadustat Phase 3 Studies
    Pooled Results of Roxadustat Phase 3 StudiesApril 15th, 2021
  • Join now to see all

Grant Support

  • Differential Effects Of Doxercalciferol (HECTORAL) And 19-Nor-1,25 DihydroxyNational Center For Research Resources2005